about
Factors Affecting Serum Concentrations of Hepatitis C Virus (HCV) RNA in HCV Genotype 1-Infected Patients with Chronic HepatitisCoinfection with Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical OutcomesHigh levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treaComparison of hepatitis C viral loads in patients with or without human immunodeficiency virusHepatitis C virus transmission bottlenecks analyzed by deep sequencing.Reciprocal interaction of human immunodeficiency virus and hepatitis C virus infectionsProteome-wide anti-hepatitis C virus (HCV) and anti-HIV antibody profiling for predicting and monitoring the response to HCV therapy in HIV-coinfected patientsCorrelates of high hepatitis C virus RNA load in a cohort of HIV-negative and HIV-positive individuals with haemophilia.Coinfection with HIV and HCV: more questions than answers?Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, CanadaGenetic divergence of hepatitis C virus: the role of HIV-related immunosuppression.Hepatitis C and human immunodeficiency virus infection.Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs.Hepatitis C in HIV-infected individuals: cure and control, right now.HCV viremia is associated with drug use in young HIV-1 and HCV coinfected pregnant and non-pregnant women.Coinfection with HIV-1 and HCV--a one-two punch.Factors associated with seronegative chronic hepatitis C virus infection in HIV infectionChronic hepatitis C virus infection and increases in viral load in a prospective cohort of young, HIV-uninfected injection drug usersFactors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 studyCD4+ T-Cell-Dependent Reduction in Hepatitis C Virus-Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency VirusHCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associationsHCV-HIV coinfection: simple messages from a complex disease.Opportunities in proteomics to understand hepatitis C and HIV coinfection.Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women.Treatment of hepatitis C in HIV-coinfected patients.Acute hepatitis C virus infection in a nurse trainee following a needlestick injury.The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use.Substance abuse, HIV-1 and hepatitisHIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study.Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users.Adaptive immunity to the hepatitis C virus.What does the pharmacological future of treating chronic hepatitis C look like?Behavioural, not biological, factors drive the HCV epidemic among HIV-positive MSM: HCV and HIV modelling analysis including HCV treatment-as-prevention impact.Virologic and immunologic aspects of HIV-hepatitis C virus coinfection.Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection.BMI, male sex and IL28B genotype associated with persistently high hepatitis C virus RNA levels among chronically infected drug users up to 23 years following seroconversion.Stability of hepatitis C virus (HCV) RNA levels among interferon-naïve HIV/HCV-coinfected individuals treated with combination antiretroviral therapy.Challenges in the treatment of chronic hepatitis C in the HIV/HCV-coinfected patient.Hepatitis C at the israeli national hemophilia center.Natural History of Hepatitis C.
P2860
Q27480999-AB566640-4449-4C67-B260-C4DB8FCB1A07Q27488883-5F1B495E-C30B-4A37-AD22-AE71B09CDF38Q27490328-DE96BDFB-430B-4AC7-83DE-2D3B123E630DQ28367786-4BF8B2E7-6C12-45CA-9562-22E13CF95F83Q33877425-3170B2F8-5523-41A5-982F-0F304ECD04A6Q33999381-9A1D0732-0D40-42EC-B502-E89D6935D6E1Q34075720-55B7C566-F1E9-48E3-9456-46F12C6B4888Q34088623-38581224-CE46-4E19-983A-1783CD4323BDQ34113786-735FD5D0-BADD-4B1A-A7A3-FE09DCDDF726Q34415820-35650F29-0E73-4CB3-BC60-F1ADBEF6B4F5Q34764615-31CB67C6-0F1F-4FC9-A666-BF144F747AAAQ34984125-80B272DB-1AFA-43FB-9881-B4C208545C52Q35033949-C302A6CE-D27D-4E89-8E09-BC32D3297A93Q35047562-866DF370-7617-4406-B2A7-6743EA6909D5Q35056682-04335B86-0859-4A3D-AE1D-9404C630DA70Q35137038-47D40DE8-6CBD-4C2E-B41D-4C6BA67FDDD3Q35206642-9C454336-FE49-426D-BBE4-21E290210ED3Q35501675-8D40EA73-C8EC-4B7A-A6B5-543A9F04B686Q35832850-810C45EF-962E-4458-8933-69ACC618C535Q35993488-E0F2C147-53DB-4B4D-8A01-466EB06BD8CCQ36013021-DDCFDB8B-F06A-495C-9672-25A57D3CDD0EQ36026387-1AE75482-EFF8-447D-ADA7-4E005FBED855Q36344202-F72A07FD-D858-4A79-B689-96D71C8823A6Q36384812-07212F31-8F86-4729-BB5D-F9A6A1FCEFC0Q36409500-21F59678-2022-4B5D-A1AA-CD08D23AA8DAQ36572537-6CAF4A25-7530-4A96-9FB6-6FF558886D1AQ36575228-0CAE558A-EE3D-4CFA-8A9C-50F0D01A401DQ37003023-AD7581FA-2463-4F1D-8AA7-FA73C6DF6AA7Q37003644-18EA9323-0574-4480-958D-71182CFF8F48Q37420620-CC307014-4C2E-48A5-913B-8B2DA266E7C6Q37805839-8188E917-0A8A-4DC7-9D08-CF5C2615DD6CQ38569681-D102ADD7-69A0-45AD-8DB9-B3DFD5913D9FQ38729837-AC3D3241-DB16-49B6-9C21-0460B2C6222DQ38900456-04305277-F81F-4689-A192-A672FF7E3422Q40341996-702A1AB4-C3DF-4BC8-BF35-194EAD162722Q41760019-0C409992-7036-47A9-82CA-E1CBF7C9A5F0Q42990589-2AB14107-DC3B-4F64-BAD1-26392C3ED672Q44369266-4C00C6B1-E547-4BA4-BD7E-489F083BFCBDQ45855099-1CD8BCE5-A00C-4025-A253-761EAE6F0B85Q50934392-2F136D60-5263-4E83-AABE-F542502ED340
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Determinants of the quantity of hepatitis C virus RNA.
@ast
Determinants of the quantity of hepatitis C virus RNA.
@en
type
label
Determinants of the quantity of hepatitis C virus RNA.
@ast
Determinants of the quantity of hepatitis C virus RNA.
@en
prefLabel
Determinants of the quantity of hepatitis C virus RNA.
@ast
Determinants of the quantity of hepatitis C virus RNA.
@en
P2093
P356
P1476
Determinants of the quantity of hepatitis C virus RNA
@en
P2093
D L Thomas
J Astemborski
K E Nelson
S A Strathdee
P304
P356
10.1086/315314
P407
P577
2000-03-01T00:00:00Z